Brickell Biotech, Inc.

Pharmaceutical ManufacturingColorado, United States11-50 Employees

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing prescription therapeutics for dermatologic diseases, with an emphasis on conditions such as hyperhidrosis and other prevalent skin disorders. Its pipeline centers on novel therapies aimed at non-invasive or differentiated treatment approaches, addressing unmet needs in the global dermatology market. Based in Boulder, Colorado, the company operates within the pharmaceutical manufacturing industry and pursues in-licensing, acquisitions, development, and eventual commercialization of innovative dermatology-focused products.

Brickell emphasizes executive and board leadership with extensive experience in product development and global commercialization, underscoring its strategy to leverage established expertise to advance therapies through development and potential future markets. The company engages in collaborations and partnerships to support its clinical program progression and has pursued relationships with other pharmaceutical entities to advance its research initiatives in dermatology and related autoimmune or debilitating diseases. The most recent publicly noted developments include asset disposition related to a skin-related treatment, illustrating ongoing portfolio and collaboration activity in the field.

Sign up for free to view info

Email Format Employee directory